Opportunity Information: Apply for PAR 13 096

  • The National Institutes of Health in the education health sector is offering a public funding opportunity titled "Planning for a National Center for Particle Beam Radiation Therapy Research (P20)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.395 Cancer Treatment Research.
  • This funding opportunity was created on Oct 17, 2013 and posted on Jan 28, 2013.
  • Applicants must submit their applications by Oct 17, 2013. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Each selected applicant is eligible to receive up to $500,000.00 in funding.
  • Eligible applicants include: Private institutions of higher education Native American tribal governments (Federally recognized) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Special district governments City or township governments County governments Others (see text field entitled Additional Information on Eligibility for clarification) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) State governments Public and State controlled institutions of higher education For profit organizations other than small businesses Small businesses.
  • Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Asian American Native American Pacific Islander Serving Institutions (AANAPISISs) Eligible Agencies of the Federal Government Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession Non domestic (non U.S.) Entities (Foreign Institutions) are not eligible to apply. Non domestic (non U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
Apply for PAR 13 096

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Opportunity Summary:

The NIH National Cancer Institute funding opportunity PAR-13-096 supports planning activities to set up a National Center for Particle Beam Radiation Therapy (PBRT) Research. The key point is that this grant is not meant to build or pay for a particle therapy clinical facility. Instead, it funds the upfront planning needed to create a research center that will operate alongside a separate, independently funded, sustainable clinical PBRT facility. The envisioned end state is a research center that can conduct clinically relevant studies using proton therapy and heavier ion beams, including (but not limited to) carbon ion beams, and that is positioned to compete successfully for larger, longer-term funding to actually run a specialized national research program in clinical PBRT.

The FOA is designed to help institutions assemble the full set of resources needed to do strong basic, translational, and clinical research that complements a working PBRT clinic. That includes building a coordinated multidisciplinary team and mapping out the expertise and infrastructure required to carry out a modern particle therapy research agenda. The announcement explicitly emphasizes cross-cutting collaboration among physicists, engineers, biologists, and physicians, reflecting the fact that particle therapy research spans beam physics and dosimetry, treatment planning and delivery engineering, radiobiology, and clinical trial design and execution. On the facilities side, the FOA highlights the types of supporting research capabilities that may need to be incorporated or strengthened, such as cell culture laboratories and vivarium resources for preclinical work, as well as specialized clinical support units like pediatric anesthesia capabilities, which can be essential for safely treating and studying certain patient populations in a particle therapy setting.

The overall objective of the planning effort is to produce a credible, integrated blueprint for a national research resource centered on PBRT. In practical terms, applicants are expected to use the planning period to define the center structure, governance, collaborations, research focus areas, and operational needs; identify and close gaps in expertise or shared resources; and lay out how the research program will interface with the independently funded clinical facility. The FOA frames this as capacity-building for a research center that can deliver high-quality, clinically meaningful work rather than isolated projects, and it makes clear that the planning should be grounded in the realities of conducting research in an active particle therapy clinical environment.

Administratively, this is a discretionary grant mechanism in the NIH portfolio, using the P20 activity code, which is typically associated with exploratory or developmental center planning. The opportunity falls under the health and education funding activity categories and is linked to CFDA 93.395 (Cancer Treatment Research). The award ceiling is listed as $500,000, and there is no cost sharing or matching requirement, which lowers barriers for applicants who can demonstrate strong institutional commitment and access to an appropriate PBRT clinical platform funded through other means.

Eligibility is broad across U.S.-based organizations. Eligible applicants include public and state-controlled institutions of higher education, private institutions of higher education, nonprofit organizations with and without 501(c)(3) status, state and local governments (including counties, cities or townships, and special district governments), federally recognized tribal governments and other tribal organizations, and for-profit organizations (including small businesses and other for-profit entities outside the small business category). The FOA also specifies eligibility for a range of mission-focused higher education institutions, including HBCUs, Hispanic-serving institutions, Tribally Controlled Colleges and Universities, and Alaska Native and Native Hawaiian-serving institutions, as well as AANAPISI-designated organizations. Foreign institutions and non-U.S. components of U.S. organizations are not eligible to apply, although foreign components as defined under NIH policy are permitted, meaning applicants may include certain international elements if they fit NIH definitions and rules, but the applicant organization itself must be domestic.

In terms of timing and lifecycle, the opportunity was posted January 28, 2013, with an original closing date of January 21, 2014, and an archive date of November 17, 2013. The record also lists dates associated with creation and closing that reflect the historical status of the announcement. While those dates indicate this particular FOA is archived, the summary still matters because it shows what NCI was looking to catalyze: an organized national-scale PBRT research center concept that leverages an existing or separately financed clinical particle therapy facility and builds the team science, shared infrastructure planning, and program design needed to compete for subsequent, operational center-level funding.

The simplest way to think about PAR-13-096 is that it pays for the intellectual and organizational work of designing a PBRT research center that can function as a national resource. It supports planning a program that spans laboratory radiobiology and engineering through clinical studies, all anchored to a real clinical particle therapy facility that is already funded outside the grant. The intended outcome is not a constructed building or purchased accelerator, but a well-justified, well-governed, and realistically resourced center plan that is ready to move into full-scale implementation once operational funding is obtained.

FAQs: NIH NCI PAR-13-096 (P20) Planning Grant for a National Center for Particle Beam Radiation Therapy (PBRT) Research

1) What is PAR-13-096 intended to support?

PAR-13-096 supports planning activities to set up a National Center for Particle Beam Radiation Therapy (PBRT) Research. The funding is meant to pay for the upfront intellectual, organizational, and coordination work needed to design a credible national-scale PBRT research center.

2) Does this grant pay to build a particle therapy clinical facility?

No. The opportunity explicitly states it is not meant to build or pay for a particle therapy clinical facility. Applicants are expected to have access to a separately funded, independently supported, sustainable clinical PBRT facility that the research center will operate alongside.

3) What is the end goal of the planning effort?

The goal is to produce an integrated, realistic blueprint for a national PBRT research resource. The planned center should be positioned to compete successfully for larger, longer-term funding to run a specialized national research program in clinical PBRT.

4) What types of particle beams are envisioned for the research program?

The envisioned research center should be able to conduct clinically relevant studies using proton therapy and heavier ion beams, including (but not limited to) carbon ion beams.

5) What kinds of research does the FOA expect the center to be able to support?

The FOA describes a center concept capable of strong basic, translational, and clinical research that complements an active PBRT clinic, rather than a collection of isolated projects.

6) What multidisciplinary collaborations are emphasized?

The announcement emphasizes cross-cutting collaboration among physicists, engineers, biologists, and physicians. This reflects the scope of particle therapy research across beam physics and dosimetry, treatment planning and delivery engineering, radiobiology, and clinical trial design and execution.

7) What facility or support capabilities are highlighted as potentially important for the planning process?

The FOA highlights planning for supporting research capabilities that may need to be incorporated or strengthened, such as cell culture laboratories and vivarium resources for preclinical work. It also notes specialized clinical support units that can be essential in a particle therapy setting, such as pediatric anesthesia capabilities.

8) What are applicants expected to deliver during the planning period?

Based on the description, applicants are expected to define the proposed center structure, governance, collaborations, research focus areas, and operational needs; identify and address gaps in expertise or shared resources; and describe how the research program will interface with the independently funded clinical PBRT facility.

9) How should the planned research center relate to the clinical PBRT facility?

The planning should be grounded in the realities of conducting research in an active particle therapy clinical environment. A key requirement is laying out how the research center will operate alongside and interface with a separate, independently funded clinical PBRT facility.

10) What funding mechanism is used for this opportunity?

This is an NIH discretionary grant mechanism using the P20 activity code, which is typically associated with exploratory or developmental center planning.

11) What is the maximum award amount listed?

The award ceiling listed for this opportunity is $500,000.

12) Is cost sharing or matching required?

No. The opportunity states there is no cost sharing or matching requirement.

13) What funding activity categories and CFDA number are associated with this FOA?

The opportunity falls under health and education funding activity categories and is linked to CFDA 93.395 (Cancer Treatment Research).

14) Who is eligible to apply?

Eligibility is broad across U.S.-based organizations. Eligible applicants include public and state-controlled institutions of higher education; private institutions of higher education; nonprofit organizations with and without 501(c)(3) status; state and local governments (including counties, cities or townships, and special district governments); federally recognized tribal governments and other tribal organizations; and for-profit organizations (including small businesses and other for-profit entities).

15) Are minority-serving and mission-focused higher education institutions included in the eligibility list?

Yes. The FOA specifies eligibility for a range of mission-focused higher education institutions, including HBCUs, Hispanic-serving institutions, Tribally Controlled Colleges and Universities, Alaska Native and Native Hawaiian-serving institutions, and AANAPISI-designated organizations.

16) Can foreign institutions apply?

No. Foreign institutions and non-U.S. components of U.S. organizations are not eligible to apply. The applicant organization itself must be domestic.

17) Are any international elements allowed at all?

Yes, the FOA indicates that foreign components (as defined under NIH policy) are permitted. This means certain international elements may be included if they fit NIH definitions and rules, even though the applicant organization must be U.S.-based.

18) What is the simplest way to describe what this grant pays for?

It pays for the intellectual and organizational work of designing a PBRT research center that can function as a national resource, anchored to a real clinical particle therapy facility that is already funded through other means.

19) What is explicitly not an intended outcome of this funding?

The intended outcome is not a constructed building, purchased accelerator, or a funded particle therapy clinic. The FOA is focused on planning and capacity-building for a research center concept that can later seek operational, center-level funding.

20) What is the status and timing information provided for this FOA?

The opportunity was posted January 28, 2013. It lists an original closing date of January 21, 2014, and an archive date of November 17, 2013. These dates indicate the FOA is archived, but the summary still describes the intended planning goals and center concept NCI sought to catalyze.

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Education Health

Next opportunity: Restoration of floodplain and side channel rearing habitat for juvenile salmonids at Knights Ferry Recreation area on the Stanislaus River, CA

Previous opportunity: Improving Implementation of Programs for Care

USGrants.org Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for PAR 13 096

 

[Watch] how do funding administrators access proposals?

Applicants also applied for:

Applicants who have applied for this opportunity (PAR 13 096) also looked into and applied for these:

Funding Opportunity
NCI Experimental Therapeutics Clinical Trials Network with Phase 1 Emphasis (ET CTN) (UM1) Apply for RFA CA 13 006

Funding Number: RFA CA 13 006
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $850,000
The Influence of the Microbiome on Preterm Labor and Delivery (R01) Apply for RFA NR 13 002

Funding Number: RFA NR 13 002
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $350,000
The Influence of the Microbiome on Preterm Labor and Delivery (R21) Apply for RFA NR 13 003

Funding Number: RFA NR 13 003
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $200,000
Collaborative Human Tissue Network (CHTN) (UM1) Apply for RFA CA 13 007

Funding Number: RFA CA 13 007
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $1,200,000
Research on Marijuana Legalization in the US (Admin Supp) Apply for PA 13 138

Funding Number: PA 13 138
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $250,000
Lasker Clinical Research Scholars Program (Si2) Apply for RFA OD 13 004

Funding Number: RFA OD 13 004
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Limited Competition Multicenter AIDS Cohort Study Center for the Coordination, Analysis, and Management of the MACS (CAMACS)(UM1) Apply for RFA AI 13 010

Funding Number: RFA AI 13 010
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $2,400,000
Limited Competition Multicenter AIDS Cohort Study (MACS) Clinical Research Sites (U01) Apply for RFA AI 13 011

Funding Number: RFA AI 13 011
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $4,200,000
Limited Competition Scholars Training for the Advancement of Research (STAR) Revision to NINR T32 Training Grants (T32) Apply for RFA NR 13 010

Funding Number: RFA NR 13 010
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
NCI Exploratory/Developmental Research Grant Program (NCI Omnibus R21) Apply for PAR 13 146

Funding Number: PAR 13 146
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $200,000
Advancing Exceptional Research on HIV/AIDS (R01) Apply for RFA DA 14 003

Funding Number: RFA DA 14 003
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders (R21) Apply for PA 13 157

Funding Number: PA 13 157
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $175,000
Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders (R21/R33) Apply for PAR 13 158

Funding Number: PAR 13 158
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
NIDA Mentored Clinical Scientists Development Program Award in Drug Abuse and Addiction (K12) Apply for PAR 13 163

Funding Number: PAR 13 163
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $500,000
Innovative Research Methods Prevention and Management of Symptoms in Chronic Illness (R01) Apply for PA 13 165

Funding Number: PA 13 165
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $350,000
Innovative Research Methods Prevention and Management of Symptoms in Chronic Illness (R15) Apply for PA 13 166

Funding Number: PA 13 166
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $300,000
Innovative Research Methods Prevention and Management of Symptoms in Chronic Illness (R21) Apply for PA 13 167

Funding Number: PA 13 167
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $200,000
The Role of Microbial Metabolites in Cancer Prevention and Etiology (U01) Apply for PAR 13 159

Funding Number: PAR 13 159
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Academic Industrial Partnerships for Translation of in vivo Imaging Systems for Cancer Investigations (R01) Apply for PAR 13 169

Funding Number: PAR 13 169
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Drug Abuse Dissertation Research (R36) Apply for PAR 13 182

Funding Number: PAR 13 182
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

USGrants.org applicant portal membership

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Subscribe to Leads

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "PAR 13 096", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.